
Wosulin 30/70 Suspension for Injection 100IU/ml
Manufacturer
Wockhardt Ltd
Salt Composition
Insulin Isophane (70%) + Human insulin (30%)
Key Information
Short Description
Wosulin 30/70 Suspension for Injection 100IU/ml is a combination of two medicines, an intermediate-acting and a short-acting type of insulin, used to treat diabetes mellitus (type 1 and 2) to improve blood sugar control in adults and children.
Dosage Form
Suspension for Injection
Introduction
Wosulin 30/70 Suspension for Injection 100IU/ml is a combination of two medicines, an intermediate-acting and a short-acting type of insulin. It is used in the treatment of diabetes mellitus (type 1 and 2) to improve blood sugar control both in adults and children. It helps maintain the blood sugar levels in diabetic patients.
Directions for Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Wosulin 30/70 Suspension for Injection 100IU/ml.
Breastfeeding Warning
Wosulin 30/70 Suspension for Injection 100IU/ml is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy Warning
Wosulin 30/70 Suspension for Injection 100IU/ml is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
How it works
Insulin Isophane has a prolonged duration of action while human insulin has a fast onset of action. Together they ensure rapid and consistent sugar control by facilitating reuptake of sugar in muscle and fat cells and suppressing the production of sugar in the liver.
Quick Tips
Take it 15 minutes before a meal or within 20 minutes after starting a meal. Injection below the skin of the abdomen results in faster absorption than other injection sites such as skin of the upper arms, thighs, or buttocks. After injection, the site of injection should not be massaged. Injection sites must be rotated to prevent hard lumps from developing at one site. Change to another type or brand of insulin should be done under strict medical supervision as it may require a change in dosage.
Related Medicines

Human Mixtard 100iu/ml Injection

Huminsulin 30/70 Injection 100iu/ml

Mixtard 30 Flexpen 100iu/ml

Mixtard 30 HM Penfill 100iu/ml (3ml)

Mixtard 30 HM Penfill 100iu/ml

Huminsulin 30/70 Cartridge 100iu/ml
